![]()
|
|
||||||||
J. Biol. Chem., Vol. 265, Issue 9, 4923-4928, Mar, 1990
HA Andree, CP Reutelingsperger, R Hauptmann, HC Hemker, WT Hermens and GM Willems
Institute for Cardiovascular Research, University of Limburg, Maastricht, The Netherlands.
Vascular anticoagulant alpha (VAC alpha, annexin V) is a member of the family of calcium and phospholipid binding proteins, the annexins. The binding properties of VAC alpha to phospholipid bilayers were studied by ellipsometry. Adsorption was calcium-dependent and completely reversible upon calcium depletion. Half-maximal adsorptions to phospholipid bilayers consisting of 100, 20, 5, and 1% dioleoyl- phosphatidylserine (DOPS) supplemented with dioleoyl- phosphatidylcholine (DOPC) were reached at Ca2+ concentrations of 0.04, 0.22, 1.5, and 8.6 mM. These surfaces all showed the same maximal adsorption of 0.22 +/- 0.01 micrograms of VAC alpha/cm2 (mean +/- S.D.). The adsorption to bilayers containing more than 10% DOPS was independent of VAC alpha concentrations in the range of 0.5-100 nM. Dissociation constants for VAC alpha binding to these surfaces were estimated to be below 2 x 10(-10) M. No adsorption was observed on pure DOPC bilayers at a Ca2+ concentration of 3 mM. The ability to mediate VAC alpha binding to 20% DOPS/80% DOPC bilayers was highly specific for Ca2+. The use of other divalent cations resulted in decreased binding in the order Cd2+ greater than Zn2+ greater than Mn2+ greater than Co2+ greater than Ba2+ greater than Mg2+. Zinc ions had a synergistic effect on Ca2(+)-dependent VAC alpha binding. The Ca2+ concentration needed for half-maximal binding to cardiolipin, dioleoyl-phosphatidylglycerol, DOPS, phosphatidylinositol, phosphatidic acid, dioleoyl- phosphatidylethanolamine, and sphingomyelin increased in that order. Adsorption was independent of the overall surface charge of the phospholipid membrane.
This article has been cited by other articles:
![]() |
B. Jeppesen, C. Smith, D. F. Gibson, and J. F. Tait Entropic and Enthalpic Contributions to Annexin V-Membrane Binding: A COMPREHENSIVE QUANTITATIVE MODEL J. Biol. Chem., March 7, 2008; 283(10): 6126 - 6135. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Akel, C. A. Wagner, J. Kovacikova, Ravi. S. Kasinathan, V. Kiedaisch, S. Koka, S. L. Alper, I. Bernhardt, T. Wieder, S. M. Huber, et al. Enhanced suicidal death of erythrocytes from gene-targeted mice lacking the Cl-/HCO3- exchanger AE1 Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1759 - C1767. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gaspersic, A. Ambrozic, B. Bozic, J. Majhenc, S. Svetina, and B. Rozman Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-{beta}2-glycoprotein I and anti-annexin A5 antibodies Rheumatology, January 1, 2007; 46(1): 81 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vicogne, D. Vollenweider, J. R. Smith, P. Huang, M. A. Frohman, and J. E. Pessin Asymmetric phospholipid distribution drives in vitro reconstituted SNARE-dependent membrane fusion PNAS, October 3, 2006; 103(40): 14761 - 14766. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hermle, E. Shumilina, P. Attanasio, A. Akel, D. S. Kempe, P. A. Lang, M. Podolski, S. Gatz, R. Bachmann, C. Bachmann, et al. Decreased cation channel activity and blunted channel-dependent eryptosis in neonatal erythrocytes Am J Physiol Cell Physiol, October 1, 2006; 291(4): C710 - C717. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Tait, C. Smith, Z. Levashova, B. Patel, F. G. Blankenberg, and J.-L. Vanderheyden Improved Detection of Cell Death In Vivo with Annexin V Radiolabeled by Site-Specific Methods J. Nucl. Med., September 1, 2006; 47(9): 1546 - 1553. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Laumonier, J. Segers, S. Laurent, A. Michel, F. Coppee, A. Belayew, L. V. Elst, and R. N. Muller A New Peptidic Vector for Molecular Imaging of Apoptosis, Identified by Phage Display Technology J Biomol Screen, August 1, 2006; 11(5): 537 - 545. [Abstract] [PDF] |
||||
![]() |
B. Han, H. Xie, Q. Chen, and J.-T. Zhang Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3{sigma}. Mol. Cancer Ther., April 1, 2006; 5(4): 903 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Klarl, P. A. Lang, D. S. Kempe, O. M. Niemoeller, A. Akel, M. Sobiesiak, K. Eisele, M. Podolski, S. M. Huber, T. Wieder, et al. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion Am J Physiol Cell Physiol, January 1, 2006; 290(1): C244 - C253. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Weihua, R. Tsan, A. J. Schroit, and I. J. Fidler Apoptotic Cells Initiate Endothelial Cell Sprouting via Electrostatic Signaling Cancer Res., December 15, 2005; 65(24): 11529 - 11535. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Richter, J. Lai Kee Him, B. Tessier, C. Tessier, and A. R. Brisson On the Kinetics of Adsorption and Two-Dimensional Self-Assembly of Annexin A5 on Supported Lipid Bilayers Biophys. J., November 1, 2005; 89(5): 3372 - 3385. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cao, J. Yang, B. R. Burkhardt, Z. Gao, R. K. Wong, S. R. Greene, J. Wu, and B. A. Wolf Effects of overexpression of pancreatic derived factor (FAM3B) in isolated mouse islets and insulin-secreting {beta}TC3 cells Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E543 - E550. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Coil and A. D. Miller Enhancement of Enveloped Virus Entry by Phosphatidylserine J. Virol., September 1, 2005; 79(17): 11496 - 11500. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shanmuganathan, D. J. Hausenloy, M. R. Duchen, and D. M. Yellon Mitochondrial permeability transition pore as a target for cardioprotection in the human heart Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H237 - H242. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. van Tits, J. de Graaf, H. Toenhake, W. van Heerde, and A. Stalenhoef C-Reactive Protein and Annexin A5 Bind to Distinct Sites of Negatively Charged Phospholipids Present in Oxidized Low-Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 717 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Lang, D. S. Kempe, V. Tanneur, K. Eisele, B. A. Klarl, S. Myssina, V. Jendrossek, S. Ishii, T. Shimizu, M. Waidmann, et al. Stimulation of erythrocyte ceramide formation by platelet-activating factor J. Cell Sci., March 15, 2005; 118(6): 1233 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. de Groot, T. J. Liu, G. Fuller, and W.K. A. Yung The Excitatory Amino Acid Transporter-2 Induces Apoptosis and Decreases Glioma Growth In vitro and In vivo Cancer Res., March 1, 2005; 65(5): 1934 - 1940. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ravassa, A. Bennaghmouch, H. Kenis, T. Lindhout, T. Hackeng, J. Narula, L. Hofstra, and C. Reutelingsperger Annexin A5 Down-regulates Surface Expression of Tissue Factor: A NOVEL MECHANISM OF REGULATING THE MEMBRANE RECEPTOR REPERTOIR J. Biol. Chem., February 18, 2005; 280(7): 6028 - 6035. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Kempe, P. A. Lang, K. Eisele, B. A. Klarl, T. Wieder, S. M. Huber, C. Duranton, and F. Lang Stimulation of erythrocyte phosphatidylserine exposure by lead ions Am J Physiol Cell Physiol, February 1, 2005; 288(2): C396 - C402. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kenis, H. van Genderen, A. Bennaghmouch, H. A. Rinia, P. Frederik, J. Narula, L. Hofstra, and C. P. M. Reutelingsperger Cell Surface-expressed Phosphatidylserine and Annexin A5 Open a Novel Portal of Cell Entry J. Biol. Chem., December 10, 2004; 279(50): 52623 - 52629. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Coil and A. D. Miller Phosphatidylserine Is Not the Cell Surface Receptor for Vesicular Stomatitis Virus J. Virol., October 15, 2004; 78(20): 10920 - 10926. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Del Gaizo Moore and R. M. Payne Transactivator of Transcription Fusion Protein Transduction Causes Membrane Inversion J. Biol. Chem., July 30, 2004; 279(31): 32541 - 32544. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Lang, S. Myssina, P. A. Lang, V. Tanneur, D. S. Kempe, A. F. Mack, S. M. Huber, T. Wieder, F. Lang, and C. Duranton Inhibition of erythrocyte phosphatidylserine exposure by urea and Cl- Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1046 - F1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rendi, N. Suh, W. W. Lamph, S. Krajewski, J. C. Reed, R. A. Heyman, A. Berchuck, K. Liby, R. Risingsong, D. B. Royce, et al. The Selective Estrogen Receptor Modulator Arzoxifene and the Rexinoid LG100268 Cooperate to Promote Transforming Growth Factor {beta}-Dependent Apoptosis in Breast Cancer Cancer Res., May 15, 2004; 64(10): 3566 - 3571. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Lang, S. Kaiser, S. Myssina, T. Wieder, F. Lang, and S. M. Huber Role of Ca2+-activated K+ channels in human erythrocyte apoptosis Am J Physiol Cell Physiol, December 1, 2003; 285(6): C1553 - C1560. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Myssina, S. M. Huber, C. Birka, P. A. Lang, K. S. Lang, B. Friedrich, T. Risler, T. Wieder, and F. Lang Inhibition of Erythrocyte Cation Channels by Erythropoietin J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2750 - 2757. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Robinson, D. T. Jones, H. Kishino, N. Goldman, and J. L. Thorne Protein Evolution with Dependence Among Codons Due to Tertiary Structure Mol. Biol. Evol., October 1, 2003; 20(10): 1692 - 1704. [Abstract] [Full Text] |
||||
![]() |
J.-Q. Kang, Z. Z. Chong, and K. Maiese Critical Role for Akt1 in the Modulation of Apoptotic Phosphatidylserine Exposure and Microglial Activation Mol. Pharmacol., September 1, 2003; 64(3): 557 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Rand, X.-X. Wu, A. S. Quinn, P. P. Chen, K. R. McCrae, E. G. Bovill, and D. J. Taatjes Human Monoclonal Antiphospholipid Antibodies Disrupt the Annexin A5 Anticoagulant Crystal Shield on Phospholipid Bilayers: Evidence from Atomic Force Microscopy and Functional Assay Am. J. Pathol., September 1, 2003; 163(3): 1193 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
H H Boersma, I H Liem, G J Kemerink, P W L Thimister, L Hofstra, L M L Stolk, W L van Heerde, M-T W Pakbiers, D Janssen, A J Beysens, et al. Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-Annexin A5 Br. J. Radiol., August 1, 2003; 76(908): 553 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. van Heerde, H. Kenis, S. Schoormans, P. Lap, C. P. M. Reutelingsperger, R. Gonzalez-Conejero, J. Corral, V. Roldan, C. Martinez, F. Marin, et al. The -1C>T mutation in the annexin A5 gene does not affect plasma levels of annexin A5 Blood, May 15, 2003; 101(10): 4223 - 4224. [Full Text] [PDF] |
||||
![]() |
J. Shi and G. E. Gilbert Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites Blood, April 1, 2003; 101(7): 2628 - 2636. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Lee, S. Miraglia, X. Yan, E. Swartzman, S. Cornell-Kennon, J. Mellentin-Michelotti, C. Bruseo, and D. S. France Oncology Drug Discovery Applications Using the FmatTM 8100 Hts System J Biomol Screen, February 1, 2003; 8(1): 81 - 88. [Abstract] [PDF] |
||||
![]() |
S. Ran, A. Downes, and P. E. Thorpe Increased Exposure of Anionic Phospholipids on the Surface of Tumor Blood Vessels Cancer Res., November 1, 2002; 62(21): 6132 - 6140. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Maddock, M. M. Mocanu, and D. M. Yellon Adenosine A3 receptor activation protects the myocardium from reperfusion/reoxygenation injury Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1307 - H1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Wakasa, T Inoue, N Kawai, J Murakami, K Kishi, and K Fukui The combination of ionizing radiation and expression of a wild type p53 gene via recombinant adenovirus induced a prominent tumour suppressing effect in human oral squamous cell carcinoma Br. J. Radiol., August 1, 2002; 75(896): 657 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawasaki, A. Nakagawa, K. Nagaosa, A. Shiratsuchi, and Y. Nakanishi Phosphatidylserine Binding of Class B Scavenger Receptor Type I, a Phagocytosis Receptor of Testicular Sertoli Cells J. Biol. Chem., July 19, 2002; 277(30): 27559 - 27566. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kunzelmann-Marche, J.-M. Freyssinet, and M. C. Martinez Loss of Plasma Membrane Phospholipid Asymmetry Requires Raft Integrity. ROLE OF TRANSIENT RECEPTOR POTENTIAL CHANNELS AND ERK PATHWAY J. Biol. Chem., May 24, 2002; 277(22): 19876 - 19881. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-O. Chay, S. S. Park, and J. F. Mushinski Linkage of Caspase-mediated Degradation of Paxillin to Apoptosis in Ba/F3 Murine Pro-B Lymphocytes J. Biol. Chem., April 19, 2002; 277(17): 14521 - 14529. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liao, B. K. Brar, Q. Cai, A. Stephanou, R. M. O'Leary, D. Pennica, D. M. Yellon, and D. S. Latchman Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion Cardiovasc Res, March 1, 2002; 53(4): 902 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. KOLIALEXI, G. T. H. TSANGARIS, A. MAVROU, A. ANTSAKLIS, F. TZORTZATOU, V. TOULIATOU, and C. METAXOTOU Use of Annexin V Antibody to Identify Apoptotic Cells during Pregnancy Ann. N.Y. Acad. Sci., September 1, 2001; 945(1): 145 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K Brar, A. Stephanou, Z. Liao, R. M O'Leary, D. Pennica, D. M Yellon, and D. S Latchman Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation Cardiovasc Res, August 1, 2001; 51(2): 265 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Meintieres, A. Biola, M. Pallardy, and D. Marzin Apoptosis can be a confusing factor in in vitro clastogenic assays Mutagenesis, May 1, 2001; 16(3): 243 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Siljander, R. W. Farndale, M. A. H. Feijge, P. Comfurius, S. Kos, E. M. Bevers, and J. W. M. Heemskerk Platelet Adhesion Enhances the Glycoprotein VI-Dependent Procoagulant Response : Involvement of p38 MAP Kinase and Calpain Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 618 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Héraud, A Héraud, and M-F Harmand Apoptosis in normal and osteoarthritic human articular cartilage Ann Rheum Dis, December 1, 2000; 59(12): 959 - 965. [Abstract] [Full Text] |
||||
![]() |
A Mamoune, S Kerdreux, V Durand, A Saraux, P Le Goff, P Youinou, and R Le Corre CD45 autoantibodies mediate neutralization of activated T cells from lupus patients through anergy or apoptosis Lupus, October 1, 2000; 9(8): 622 - 631. [Abstract] [PDF] |
||||
![]() |
A. M. Mirza, A. D. Kohn, R. A. Roth, and M. McMahon Oncogenic Transformation of Cells by a Conditionally Active Form of the Protein Kinase Akt/PKB Cell Growth Differ., June 1, 2000; 11(6): 279 - 292. [Abstract] [Full Text] |
||||
![]() |
B. K. Brar, A. K. Jonassen, A. Stephanou, G. Santilli, J. Railson, R. A. Knight, D. M. Yellon, and D. S. Latchman Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway J. Biol. Chem., March 17, 2000; 275(12): 8508 - 8514. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Helmby, G. Jonsson, and M. Troye-Blomberg Cellular Changes and Apoptosis in the Spleens and Peripheral Blood of Mice Infected with Blood-Stage Plasmodium chabaudi chabaudi AS Infect. Immun., March 1, 2000; 68(3): 1485 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L van Heerde, S. Robert-Offerman, E. Dumont, L. Hofstra, P. A Doevendans, J. F.M Smits, M. J.A.P Daemen, and C. P.M Reutelingsperger Markers of apoptosis in cardiovascular tissues: focus on Annexin V Cardiovasc Res, February 1, 2000; 45(3): 549 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J.B van den Hoff, S. M van den Eijnde, S. Viragh, and A. F.M Moorman Programmed cell death in the developing heart Cardiovasc Res, February 1, 2000; 45(3): 603 - 620. [Full Text] [PDF] |
||||
![]() |
C. Albanese, M. D'Amico, A. T. Reutens, M. Fu, G. Watanabe, R. J. Lee, R. N. Kitsis, B. Henglein, M. Avantaggiati, K. Somasundaram, et al. Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis J. Biol. Chem., November 26, 1999; 274(48): 34186 - 34195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. BONOMINI, V. SIROLLI, N. SETTEFRATI, S. DOTTORI, L. DI LIBERATO, and A. ARDUINI Increased Erythrocyte Phosphatidylserine Exposure in Chronic Renal Failure J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1982 - 1990. [Abstract] [Full Text] |
||||
![]() |
C. Gidon-Jeangirard, B. Hugel, V. Holl, F. Toti, J.-L. Laplanche, D. Meyer, and J.-M. Freyssinet Annexin V Delays Apoptosis While Exerting an External Constraint Preventing the Release of CD4+ and PrPc+ Membrane Particles in a Human T Lymphocyte Model J. Immunol., May 15, 1999; 162(10): 5712 - 5718. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Vincent and K. Maiese Direct Temporal Analysis of Apoptosis Induction in Living Adherent Neurons J. Histochem. Cytochem., May 1, 1999; 47(5): 661 - 672. [Abstract] [Full Text] |
||||
![]() |
C. Bonzon and H. Fan Moloney Murine Leukemia Virus-Induced Preleukemic Thymic Atrophy and Enhanced Thymocyte Apoptosis Correlate with Disease Pathogenicity J. Virol., March 1, 1999; 73(3): 2434 - 2441. [Abstract] [Full Text] |
||||
![]() |
G Taimor, H Lorenz, B Hofstaetter, K.-D Schluter, and H.M Piper Induction of necrosis but not apoptosis after anoxia and reoxygenation in isolated adult cardiomyocytes of rat Cardiovasc Res, January 1, 1999; 41(1): 147 - 156. |